Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Statera Biopharma Inc
(NQ:
STAB
)
0.2399
-0.0021 (-0.87%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 27, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
982,141
Open
0.2497
Bid (Size)
0.2391 (3)
Ask (Size)
0.2475 (50)
Prev. Close
0.2420
Today's Range
0.2253 - 0.2497
52wk Range
0.2019 - 4.660
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
Analyzing Statera BioPharma's Short Interest
May 17, 2022
Statera BioPharma's (NASDAQ:STAB) short percent of float has risen 287.8% since its last report. The company recently reported that it has 647.70 thousand shares sold short, which...
Via
Benzinga
The Daily Biotech Pulse: FDA Orphan Drug Tags For Neurocrine, Editas Candidates; Sale of BridgeBio's PRV; RMAT Designation For PolarityTE's Product
May 13, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Performance
YTD
-89.43%
-89.43%
1 Month
-36.89%
-36.89%
3 Month
-71.52%
-71.52%
6 Month
-92.41%
-92.41%
1 Year
-92.31%
-92.31%
More News
Read More
12 Health Care Stocks Moving In Friday's Intraday Session
April 29, 2022
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
April 29, 2022
Via
Benzinga
Why Is Statera Biopharma (STAB) Stock Up Today?
April 28, 2022
Via
InvestorPlace
Why Are Statera Biopharma Shares Surging Today
April 28, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
April 26, 2022
Via
Benzinga
Coeptis Therapeutics Intends To Acquire Statera's TLR5 Agonist Platform
April 13, 2022
Via
Benzinga
70 Biggest Movers From Friday
May 02, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
April 29, 2022
Via
InvestorPlace
48 Stocks Moving In Friday's Mid-Day Session
April 29, 2022
Via
Benzinga
28 Stocks Moving in Friday's Pre-Market Session
April 29, 2022
Via
Benzinga
74 Biggest Movers From Yesterday
April 29, 2022
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
April 28, 2022
Via
Benzinga
Mid-Afternoon Market Update: Nasdaq Jumps 400 Points; Sio Gene Therapies Shares Plummet
April 28, 2022
Via
Benzinga
Mid-Day Market Update: Teladoc Health Drops Following Q1 Results; Swvl Holdings Shares Jump
April 28, 2022
Via
Benzinga
How Is The Market Feeling About Statera Biopharma Inc. - Common Stock?
April 28, 2022
Via
Benzinga
The Daily Biotech Pulse: Moderna Seeks FDA Approval For COVID-19 Shot For Children 2-6, Tax Disclosure For Amgen, Fast Track Tags For SQZ Biotech, Timber Pharma Candidates
April 28, 2022
Via
Benzinga
48 Stocks Moving In Thursday's Mid-Day Session
April 28, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
April 28, 2022
Via
InvestorPlace
28 Stocks Moving in Thursday's Pre-Market Session
April 28, 2022
Via
Benzinga
Earnings Scheduled For March 31, 2022
March 31, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
April 01, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
March 29, 2022
Via
Benzinga
InvestorNewsBreaks – Statera Biopharma Inc. (NASDAQ: STAB) Announces Public Offering Pricing
March 24, 2022
Via
Investor Brand Network
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.